TIBER CREEK GROUP for CIGNA CORPORATION AND SUBSIDIARIES
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to Medicare drug coverage, specialty pharmacy, and general prescription drug pricing policy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAN BEUKELMAN | — |
| NIKOLE BURROUGHS | — |
| ANDREW MCKECHNIE | — |
| JOHN KIRKLAND TWOMEY | — |
Health Issues HCR
Issues related to proposals impacting employer sponsored insurance; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy and telehealth; Issues related to an extension of enhanced premium tax credits and health insurance affordability; Issues related to tax and health coverage changes in the One Big Beautiful Bill Act (PL 119-21); Issues related to competition in the health care marketplace.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAN BEUKELMAN | — |
| NIKOLE BURROUGHS | — |
| ANDREW MCKECHNIE | — |
| JOHN KIRKLAND TWOMEY | — |
Defense DEF
Pharmacy issues related to H.R. 3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; Pharmacy issues related to S. 2296 - National Defense Authorization Act for Fiscal Year 2026.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAN BEUKELMAN | — |
| NIKOLE BURROUGHS | — |
| ANDREW MCKECHNIE | — |
| JOHN KIRKLAND TWOMEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.